Blind sub-trial | Non-blind sub-trial | HT vs. no HT6 | |||
---|---|---|---|---|---|
HT, % | Placebo, % | HT, % | Placebo, % | OR (95% CI) | |
Exercise | |||||
1 st year 2 | |||||
Little/none | 20 | 25 | 25 | 24 | 0.88 (0.68–1.14) |
(Rather) much | 42 | 347 | 33 | 37 | 1.08 (0.86–1.35) |
Final survey 3 | |||||
Little/none | 27 | 358 | 32 | 35 | 0.78 (0.62–0.97) |
(Rather) much | 33 | 26 | 27 | 30 | 1.10 (0.88–1.39) |
BMI | |||||
1st year4 | |||||
25–29 | 41 | 38 | 39 | 40 | 1.01 (0.81–1.27) |
≥ 30 | 23 | 21 | 25 | 23 | 1.12 (0.86–1.45) |
Final survey5 | |||||
25–29 | 38 | 39 | 39 | 43 | 0.91 (0.73–1.13) |
≥ 30 | 24 | 24 | 27 | 22 | 1.16 (0.91–1.48) |